Robin Mogg

45 papers receiving 2.8k citations

Robin Mogg's Hit Papers

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study 2018 · 285 citations
2850+6+12Years since publication4008001.2k

Peers

Robin Mogg
Comparison fields: 5 of 129
  • Virology 809
  • Immunology 702
  • Infectious Diseases 548
  • Neurology 229
  • Epidemiology 460
Replace Joseph A. Church with:
Joseph A. Church United States
Hernán Valdez United States
Dominique Salmon France
Ole S. Søgaard Denmark
David Chernoff United States
Julian Schulze zur Wiesch Germany
Arthur Y. Kim United States
Joseph Chiu United States
Michel Moutschen Belgium
Armin Rieger Austria
Robin Mogg relative to Joseph A. Church United States Joseph A. Church's profile →
Citations per field
00.5×4.0×
Joseph A. Church · 1×
Citations per year

Countries citing papers authored by Robin Mogg

Since Specialization
Citations

This map shows the geographic impact of Robin Mogg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Mogg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Mogg more than expected).

Fields of papers citing papers by Robin Mogg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Mogg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Mogg. The network helps show where Robin Mogg may publish in the future.

Co-authors

The 25 scholars most cited alongside Robin Mogg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin Mogg Line = papers co-authored together Robin Mogg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Hit paper breakdown →
20081290
2 2013318
3
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Hit paper breakdown →
2018285
4 2009177
5 2021123
6 200775
7 200762
8 202259
9 201655
10 200948
11 201741
12 201834
13 202132
14 202130
15 200627
16 200819
17 201618
18 200615
19 202213
20 201412

About Robin Mogg

Robin Mogg is a scholar working on Infectious Diseases, Oncology, Virology, Statistics and Probability and Cancer Research, having authored 46 papers that have together received 2.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Statistical Methods in Clinical Trials (6 papers), Hepatitis C virus research (5 papers), HIV/AIDS drug development and treatment (5 papers), Cancer Genomics and Diagnostics (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Asthma and respiratory diseases (3 papers). The work is most often cited by research in Virology (809 citations), Immunology (702 citations), Infectious Diseases (548 citations), Neurology (229 citations) and Epidemiology (460 citations). Robin Mogg has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Devan V. Mehrotra, Danilo R. Casimiro, Michael Robertson, Michael Marmor, M. Juliana McElrath, Ann Duerr, Javier R. Lama, Susan Buchbinder, Lawrence Corey and Keith Gottesdiener. Their work appears in journals such as Journal of Clinical Oncology, Statistics in Medicine, JAIDS Journal of Acquired Immune Deficiency Syndromes, Open Forum Infectious Diseases and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact